1. Home
  2. TLSA vs RDZN Comparison

TLSA vs RDZN Comparison

Compare TLSA & RDZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

HOLD

Current Price

$1.22

Market Cap

155.2M

Sector

Health Care

ML Signal

HOLD

Logo Roadzen Inc.

RDZN

Roadzen Inc.

HOLD

Current Price

$1.19

Market Cap

148.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLSA
RDZN
Founded
2013
2015
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
155.2M
148.7M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
TLSA
RDZN
Price
$1.22
$1.19
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
108.5K
89.1K
Earning Date
05-06-2025
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$33.77
Revenue Next Year
N/A
$51.46
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$0.68
52 Week High
$2.60
$2.56

Technical Indicators

Market Signals
Indicator
TLSA
RDZN
Relative Strength Index (RSI) 38.51 39.86
Support Level N/A $1.12
Resistance Level $1.56 $1.20
Average True Range (ATR) 0.09 0.08
MACD -0.01 0.01
Stochastic Oscillator 8.62 27.87

Price Performance

Historical Comparison
TLSA
RDZN

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, Alzheimer's, and ALS. Its flagship immunotherapeutic candidate, Foralumab (TZLS-401), which is a fully human anti-CD3 monoclonal antibody, is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's and other CNS indications.

About RDZN Roadzen Inc.

Roadzen Inc is an insurance technology company on a mission to transform auto insurance powered by AI. Its clients comprise insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.

Share on Social Networks: